Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL265 Target Snapshot

D(1A) dopamine receptor · SINGLE PROTEIN · Rattus norvegicus

1,241Compounds
284Assays
24Approved Drugs
1,503.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P18901. Use UniProt P18901 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P18901 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats D(1A) dopamine receptor as ChEMBL target CHEMBL265, mapped to UniProt P18901. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
D(1A) dopamine receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL265
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P18901
D(1A) dopamine receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether D(1A) dopamine receptor is the right protein anchor across sources, using UniProt P18901 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD(1A) dopamine receptor
UniProt AccessionP18901
Component TypeProtein
Sequence Length446 aa

D(1A) dopamine receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as D(1A) dopamine receptor, mapped to UniProt P18901. Sequence length is 446 aa.

Mapped IDP18901
Review nameD(1A) dopamine receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

24
Approved
1
Phase III
14
Phase II
Assay Mix

Activity Type Distribution

IC50450.0
KI982.0
EC5067.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL441618 10.1 Ki 0.08 Preclinical
CHEMBL3763331 10.01 Ki 0.0983 Preclinical
CHEMBL62 9.92 Ki 0.12 Preclinical
CHEMBL13632 9.59 Ki 0.26 Preclinical
CHEMBL1185 9.52 Kd 0.3 Approved
CHEMBL54661 9.52 IC50 0.3 Preclinical
CHEMBL136190 9.43 IC50 0.37 Preclinical
CHEMBL87734 9.31 Ki 0.49 Preclinical
CHEMBL62 9.24 IC50 0.57 Preclinical
CHEMBL393466 9.19 Ki 0.6427 Preclinical
Distribution

pChEMBL Value Distribution

127
5.0
167
5.5
186
6.0
139
6.5
119
7.0
103
7.5
59
8.0
65
8.5
31
9.0
7
9.5
pChEMBL
Approved Drugs

Approved Drugs

ARIPIPRAZOLE
CHEMBL1112
Approved 2002
APOMORPHINE
CHEMBL53
Approved 2001
APOMORPHINE HYDROCHLORIDE
CHEMBL3187985
Approved 2001
ZOLMITRIPTAN
CHEMBL1185
Approved 1997
FENOLDOPAM
CHEMBL588
Approved 1997
SERTINDOLE
CHEMBL12713
Approved 1996
OLANZAPINE
CHEMBL715
Approved 1996
RISPERIDONE
CHEMBL85
Approved 1993
CLOZAPINE
CHEMBL42
Approved 1989
DOPAMINE
CHEMBL59
Approved 1974
HALOPERIDOL
CHEMBL54
Approved 1967
THIORIDAZINE
CHEMBL479
Approved 1962
CHLORPROMAZINE
CHEMBL71
Approved 1957
Assay Landscape

Assay Landscape

284
Total Assays
809
Tested Compounds
2
Assay Types
Binding — 244 assays, 809 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 87 297 6.8
assay format 65 197 6.8
cell membrane format 47 174 6.1
tissue-based format 38 130 6.7
cell-based format 4 6 6.6
organism-based format 2 2 9.2
subcellular format 1 3 5.0
Functional — 40 assays, 43 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 21 17 6.4
tissue-based format 8 17 7.1
cell membrane format 7 7 5.8
cell-based format 3 2 6.6
organism-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine